Intensive lipid-lowering strategy dynamite in CAD

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1479, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New lipid-lowering agents

By Wierzbicki Anthony S  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of lipid-lowering therapies

By Hu Miao   Tomlinson Brian  

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 981-995

Future Medicine

Access to resources Recommend Favorite

Lipid-lowering therapy in diabetes

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Lipid-lowering therapies in development

By Wierzbicki Anthony S  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1405-1418

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US

By Rosen Virginia M.  

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 47-60

Adis International

Access to resources Recommend Favorite